Loading...
Targeting focal adhesion kinase overcomes erlotinib resistance in smoke induced lung cancer by altering phosphorylation of epidermal growth factor receptor
EGFR-based targeted therapies have shown limited success in smokers. Identification of alternate signaling mechanism(s) leading to TKI resistance in smokers is critically important. We observed increased resistance to erlotinib in H358 NSCLC (non-small cell lung carcinoma) cells chronically exposed...
Saved in:
| Published in: | Oncoscience |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Impact Journals LLC
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5854290/ https://ncbi.nlm.nih.gov/pubmed/29556515 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncoscience.395 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|